Literature DB >> 25297490

[Prostate cancer in routine healthcare: health-related quality of life after inpatient treatment].

S Henninger1, S Neusser, C Lorenz, E M Bitzer.   

Abstract

BACKGROUND: Prostate cancer (PCA) is the most common form of neoplasm in men and various treatment options are available. Knowledge of health-related quality of life (HRQL) can provide information to support informed decision-making. In addition, information on factors influencing HRQL can provide indications for the further development of medical treatment. The aim of the study was to obtain data on HRQL after inpatient treatment of PCA and the identification of determinants of HRQL after PCA in routine healthcare.
MATERIALS AND METHODS: In this study a total of 1165 beneficiaries of a German health insurance with a hospital stay due to prostate cancer (ICD C61) were surveyed on their health-related quality of life using the European Organization for Research and Treatment of Cancer quality of life questionnaire version 3 (EORTC QLQ-C30 V3.0) and disease-specific symptoms using the perceived sensitivity to medicine (PSM) scale 14 months after discharge. Survey data were linked with pseudonymous claims data of the health insurance provider. Determinants of HRQL were examined by logistic regression.
RESULTS: Responses from 825 men (mean age 67.6 years and 80% treated with radical prostatectomy) were available for analysis (response 70.8%). Compared to the reference population impairments in HRQL were reported especially in terms of the roles and social functionality. The prostate-specific symptoms varied depending on the treatment strategy. A nerve-sparing surgical technique reduced the likelihood of erectile dysfunction. Other protective factors were no pre-existing comorbidities and younger age. DISCUSSION: The effects of PCA on the HRQOL varied by age, comorbidities and treatment modality which should be considered in healthcare information and counseling of patients.

Entities:  

Mesh:

Year:  2014        PMID: 25297490     DOI: 10.1007/s00120-014-3615-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  22 in total

1.  Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.

Authors:  K Cocks; M T King; G Velikova; G de Castro; M Martyn St-James; P M Fayers; J M Brown
Journal:  Eur J Cancer       Date:  2012-03-12       Impact factor: 9.162

2.  Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.

Authors:  Montserrat Ferrer; José Francisco Suárez; Ferran Guedea; Pablo Fernández; Víctor Macías; Alfonso Mariño; Asunción Hervas; Ismael Herruzo; María José Ortiz; Humberto Villavicencio; Jordi Craven-Bratle; Olatz Garin; Ferran Aguiló
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-05       Impact factor: 7.038

3.  Quality of life in men receiving radiotherapy and neo-adjuvant androgen deprivation for prostate cancer: results from a prospective longitudinal study.

Authors:  Eilis Mc Caughan; Oonagh Mc Sorley; Gillain Prue; Kader Parahoo; Brendan Bunting; Joe O Sullivan; Hugh McKenna
Journal:  J Adv Nurs       Date:  2012-03-27       Impact factor: 3.187

4.  [Quality of life after prostate cancer in members of support groups: first results of the HAROW retro study].

Authors:  B Bestmann; T Kollakowski; L Weissbach
Journal:  Urologe A       Date:  2011-03       Impact factor: 0.639

5.  Does quality of life of prostate cancer patients differ by stage and treatment?

Authors:  Giedrius Vanagas; Ausra Mickeviciene; Albertas Ulys
Journal:  Scand J Public Health       Date:  2012-12-04       Impact factor: 3.021

6.  Differences in health-related quality of life of prostate cancer patients based on stage of cancer.

Authors:  Barry Rosenfeld; Andrew J Roth; Sanjay Gandhi; David Penson
Journal:  Psychooncology       Date:  2004-11       Impact factor: 3.894

Review 7.  Prostate cancer and health-related quality of life: a review of the literature.

Authors:  David T Eton; Stephen J Lepore
Journal:  Psychooncology       Date:  2002 Jul-Aug       Impact factor: 3.894

8.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

9.  Living alone, obesity and smoking: important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer.

Authors:  Karin B Dieperink; Steinbjørn Hansen; Lis Wagner; Christoffer Johansen; Klaus K Andersen; Olfred Hansen
Journal:  Acta Oncol       Date:  2012-07       Impact factor: 4.089

10.  Normative data of the EORTC QLQ-C30 for the German population: a population-based survey.

Authors:  Annika Waldmann; Daniel Schubert; Alexander Katalinic
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

View more
  1 in total

1.  Socioeconomic status and health-related quality of life among patients with prostate cancer 6 months after radical prostatectomy: a longitudinal analysis.

Authors:  Jens Klein; Kerstin Hofreuter-Gätgens; Daniel Lüdecke; Margit Fisch; Markus Graefen; Olaf von dem Knesebeck
Journal:  BMJ Open       Date:  2016-06-03       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.